PT819002E - USES OF IMIDAZOLIC-1,2-A | PYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEURO-PSYCHIATRIC SYNDROMES ASSOCIATED WITH THE DIFFUSION OF THE NEURAL CIRCUITS OF BASAL GANGLIOS - Google Patents

USES OF IMIDAZOLIC-1,2-A | PYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEURO-PSYCHIATRIC SYNDROMES ASSOCIATED WITH THE DIFFUSION OF THE NEURAL CIRCUITS OF BASAL GANGLIOS

Info

Publication number: PT819002E
Authority: PT; Portugal
Prior art keywords: ganglios; imidazolic; neuro; basal; pyridine
Prior art date: 1995-04-07

Application number

PT96907656T

Other languages

Portuguese (pt)

Inventor

Elena Benincasa

Original Assignee

Clarendon Trading & Investimen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-04-07

Filing date

1996-04-02

Publication date

2003-01-31

1996-04-02 Application filed by Clarendon Trading & Investimen filed Critical Clarendon Trading & Investimen

2003-01-31 Publication of PT819002E publication Critical patent/PT819002E/en

Links

YDHIMEXEGOCNHU-UHFFFAOYSA-N 2-pyridin-3-ylacetamide Chemical class NC(=O)CC1=CC=CN=C1 YDHIMEXEGOCNHU-UHFFFAOYSA-N 0.000 title 1
238000009792 diffusion process Methods 0.000 title 1
230000001537 neural effect Effects 0.000 title 1
208000011580 syndromic disease Diseases 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PT96907656T 1995-04-07 1996-04-02 USES OF IMIDAZOLIC-1,2-A | PYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEURO-PSYCHIATRIC SYNDROMES ASSOCIATED WITH THE DIFFUSION OF THE NEURAL CIRCUITS OF BASAL GANGLIOS PT819002E (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT95RM000223A IT1276522B1 (en)	1995-04-07	1995-04-07	USE OF ZOLPIDEM FOR THE THERAPEUDIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DYSFUNSION AND NEURAL CIRCUITS OF

Publications (1)

Publication Number	Publication Date
PT819002E true PT819002E (en)	2003-01-31

Family

ID=11403250

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT96907656T PT819002E (en)	1995-04-07	1996-04-02	USES OF IMIDAZOLIC-1,2-A \| PYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEURO-PSYCHIATRIC SYNDROMES ASSOCIATED WITH THE DIFFUSION OF THE NEURAL CIRCUITS OF BASAL GANGLIOS

Country Status (25)

Country	Link
US (1)	US5891891A (en)
EP (1)	EP0819002B1 (en)
JP (1)	JP4049390B2 (en)
KR (1)	KR100425628B1 (en)
CN (1)	CN1198612C (en)
AR (1)	AR003414A1 (en)
AT (1)	ATE222763T1 (en)
AU (1)	AU707759B2 (en)
CA (1)	CA2217590C (en)
CZ (1)	CZ292020B6 (en)
DE (1)	DE69623271T2 (en)
DK (1)	DK0819002T3 (en)
EA (1)	EA000396B1 (en)
ES (1)	ES2182967T3 (en)
HU (1)	HUP9900733A3 (en)
IL (1)	IL117824A (en)
IT (1)	IT1276522B1 (en)
MX (1)	MX9707712A (en)
NO (1)	NO315408B1 (en)
NZ (1)	NZ304107A (en)
PL (1)	PL322647A1 (en)
PT (1)	PT819002E (en)
TW (1)	TW450816B (en)
WO (1)	WO1996031210A1 (en)
ZA (1)	ZA962711B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7632517B2 (en) *	1997-10-01	2009-12-15	Novadel Pharma Inc.	Buccal, polar and non-polar spray containing zolpidem
US6333345B1 (en)	1999-05-14	2001-12-25	Sepracor, Inc.	Methods of using and compositions comprising N-desmethylzolpidem
US6399621B1 (en)	1999-08-10	2002-06-04	American Cyanamid Company	N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US20030091632A1 (en) *	1999-08-26	2003-05-15	Neurocrine Biosciences, Inc.	Controlled-release sedative-hypnotic compositions and methods related thereto
US6485746B1 (en)	2000-08-25	2002-11-26	Neurocrine Biosciences, Inc.	Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en)	1999-09-02	2002-05-07	Neurocrine Biosciences, Inc.	Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
EP1272181A2 (en) *	2000-04-13	2003-01-08	Synthon B.V.	Modified release formulations containing a hypnotic agent
PL358548A1 (en) *	2000-04-24	2004-08-09	Teva Pharmaceutical Industries Ltd.	Zolpidem hemitartrate
DE10041478A1 (en) *	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	New pharmaceutical composition
DE10117183A1 (en) *	2001-04-05	2002-10-10	Gruenenthal Gmbh	Use of substituted imidazo [1,2-a] pyridine compounds as medicaments
GB0311457D0 (en) *	2003-05-19	2003-06-25	Sciencom Ltd	New therapeutic use
JP2008506630A (en) *	2003-05-19	2008-03-06	サイエンコム・リミテッド	Further therapeutic use of zolpidem
DE10334188B4 (en)	2003-07-26	2007-07-05	Schwarz Pharma Ag	Use of rotigotine to treat depression
DE10334187A1 (en) *	2003-07-26	2005-03-03	Schwarz Pharma Ag	Substituted 2-aminotetralins for the treatment of depression
WO2005060968A1 (en)	2003-12-11	2005-07-07	Sepracor Inc.	Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
DE10361258A1 (en)	2003-12-24	2005-07-28	Schwarz Pharma Ag	Use of substituted 2-aminotetralins for the preventive treatment of Parkinson's disease
CA2556870C (en)	2004-02-18	2014-01-28	Timothy J. Barberich	Dopamine-agonist combination therapy for improving sleep quality
DE102004014841B4 (en) *	2004-03-24	2006-07-06	Schwarz Pharma Ag	Use of rotigotine for the treatment and prevention of Parkinson-Plus syndrome
DE602006008339D1 (en) *	2005-11-18	2009-09-17	Synhton B V	Zolpidemtabletten
GB2443928A (en) *	2006-11-08	2008-05-21	Regen Therapeutics Plc	Transdermal pharmaceutical composition comprising Zolpidem
GB0809936D0 (en) *	2008-05-30	2008-07-09	Regen Therapeutics Plc	Therapeutic use of zolpidem
WO2017214442A1 (en)	2016-06-08	2017-12-14	President And Fellows Of Harvard College	Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome
CA3099751A1 (en)	2018-05-22	2019-11-28	President And Fellows Of Harvard College	Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
AU2019279858A1 (en)	2018-05-29	2020-11-26	President And Fellows Of Harvard College	Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
US12077512B2 (en)	2019-03-25	2024-09-03	President And Fellows Of Harvard College	Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2492382A1 (en) *	1980-10-22	1982-04-23	Synthelabo	IMIDAZO (1,2-A) PYRIDINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
US5032595A (en) *	1989-11-24	1991-07-16	Fidia-Georgetown Institute For The Neurosciences	Method of stimulating steroidogenesis with alpidem
US5206382A (en) *	1991-06-27	1993-04-27	Fidia Georgetown Institute For The Neurosciences	Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders

1995
- 1995-04-07 IT IT95RM000223A patent/IT1276522B1/en active IP Right Grant
1996
- 1996-04-02 PL PL96322647A patent/PL322647A1/en unknown
- 1996-04-02 KR KR1019970707107A patent/KR100425628B1/en not_active Expired - Fee Related
- 1996-04-02 DK DK96907656T patent/DK0819002T3/en active
- 1996-04-02 NZ NZ304107A patent/NZ304107A/en not_active IP Right Cessation
- 1996-04-02 CZ CZ19973167A patent/CZ292020B6/en not_active IP Right Cessation
- 1996-04-02 DE DE69623271T patent/DE69623271T2/en not_active Expired - Lifetime
- 1996-04-02 AT AT96907656T patent/ATE222763T1/en active
- 1996-04-02 WO PCT/IT1996/000063 patent/WO1996031210A1/en not_active Ceased
- 1996-04-02 ES ES96907656T patent/ES2182967T3/en not_active Expired - Lifetime
- 1996-04-02 CA CA002217590A patent/CA2217590C/en not_active Expired - Lifetime
- 1996-04-02 MX MX9707712A patent/MX9707712A/en unknown
- 1996-04-02 US US08/930,644 patent/US5891891A/en not_active Expired - Lifetime
- 1996-04-02 JP JP53016596A patent/JP4049390B2/en not_active Expired - Fee Related
- 1996-04-02 AU AU51200/96A patent/AU707759B2/en not_active Ceased
- 1996-04-02 HU HU9900733A patent/HUP9900733A3/en unknown
- 1996-04-02 PT PT96907656T patent/PT819002E/en unknown
- 1996-04-02 EA EA199700308A patent/EA000396B1/en not_active IP Right Cessation
- 1996-04-02 CN CNB961937815A patent/CN1198612C/en not_active Expired - Fee Related
- 1996-04-02 EP EP96907656A patent/EP0819002B1/en not_active Expired - Lifetime
- 1996-04-03 IL IL11782496A patent/IL117824A/en not_active IP Right Cessation
- 1996-04-04 ZA ZA962711A patent/ZA962711B/en unknown
- 1996-04-08 AR ARP960102094A patent/AR003414A1/en unknown
- 1996-04-15 TW TW085104484A patent/TW450816B/en not_active IP Right Cessation
1997
- 1997-10-06 NO NO19974603A patent/NO315408B1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2217590A1 (en)	1996-10-10
DE69623271D1 (en)	2002-10-02
CA2217590C (en)	2008-08-12
NO315408B1 (en)	2003-09-01
IT1276522B1 (en)	1997-10-31
WO1996031210A1 (en)	1996-10-10
PL322647A1 (en)	1998-02-16
ITRM950223A0 (en)	1995-04-07
ZA962711B (en)	1996-07-30
JP4049390B2 (en)	2008-02-20
DE69623271T2 (en)	2003-07-24
TW450816B (en)	2001-08-21
KR19980703707A (en)	1998-12-05
EP0819002B1 (en)	2002-08-28
CZ292020B6 (en)	2003-07-16
HUP9900733A2 (en)	1999-07-28
AU707759B2 (en)	1999-07-22
CN1183719A (en)	1998-06-03
NZ304107A (en)	2000-12-22
IL117824A (en)	2000-08-31
HUP9900733A3 (en)	2003-05-28
ES2182967T3 (en)	2003-03-16
NO974603L (en)	1997-11-24
AR003414A1 (en)	1998-08-05
ATE222763T1 (en)	2002-09-15
US5891891A (en)	1999-04-06
KR100425628B1 (en)	2004-06-23
CZ316797A3 (en)	1998-05-13
EP0819002A1 (en)	1998-01-21
ITRM950223A1 (en)	1996-10-07
MX9707712A (en)	1998-03-31
DK0819002T3 (en)	2003-01-06
CN1198612C (en)	2005-04-27
JPH11503149A (en)	1999-03-23
AU5120096A (en)	1996-10-23
IL117824A0 (en)	1996-08-04
EA199700308A1 (en)	1998-04-30
EA000396B1 (en)	1999-06-24
NO974603D0 (en)	1997-10-06

Publication	Publication Date	Title
NO305886B1 (en)	1999-08-16	Use of an Organic Nitrite for the Preparation of Medications for Continuous Vasodilatory Therapy
IS4570A (en)	1997-09-25	Imidazo [1,2-a] pyridine derivatives
EE9900607A (en)	2000-08-15	Imidazopyrimidines and Imidazopyridines for the Treatment of Neurological Disorders
HUP9601566A2 (en)	1997-09-29	Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
HUP9900733A3 (en)	2003-05-28	Use of imidazo[1,2-a]pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with difunction of the neural circuits of the basal ganglia
NO981008L (en)	1998-05-06	Pharmaceutical isk surface formulation
NO975661D0 (en)	1997-12-05	Use of bis-1,2,4-triazoles for the preparation of a drug for the treatment of cancer
FI961564A7 (en)	1996-04-10	Alkoxyalkylcarbamates of imidazo(1,2-a)pyridines
NO975662D0 (en)	1997-12-05	Use of 1,2,4-triazole derivatives for the preparation of a drug for the treatment of cancer
PT1105390E (en)	2003-10-31	IMIDAZO¬1,2-A \| PYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISEASES
PT879051E (en)	2003-10-31	RISPERIDONE TRANSDERMIC ADMINISTRATION WITH CONTROLLED SPEED
IT1288399B1 (en)	1998-09-22	MEDICATION FOR THE THERAPEUTIC TREATMENT OF AGE-RELATED MACULOPATHY, NON-AGE-RELATED MACULOPATHY AND FOR PROPHYLAXIS
ITRM950484A0 (en)	1995-07-14	USE OF AMTOLMETINEGUACIL (MED 15) AS AN ANTI-SECRETIVE DRUG ON THE GASTRIC AND THEREFORE GASTROPROTECTIVE.
FR2761070B1 (en)	1999-04-23	DIHYDROPYRAZINO [1,2-A] INDOLE-1-ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
NO944809L (en)	1994-12-12	Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
FR2699920B1 (en)	1995-02-10	Imidazo [2,1-b] benzothiazole-3-acetamide derivatives, their preparation and their therapeutic use.
FR2741073B1 (en)	1997-12-12	4,5-DIHYDROIMIDAZO (1,2-A) PYRROLO (1,2,3-CD) BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
NO974651D0 (en)	1997-10-08	Biologically active ureido derivatives useful in the treatment of multiple sclerosis
LV11966A (en)	1998-02-20	Anti-inflammatory medication for use
FR2700546B1 (en)	1995-02-17	Imidazo [2,1-b] benzoxazole-3-acetamide derivatives, their preparation and their therapeutic use.
ZA944671B (en)	1995-01-16	Medicaments for the treatment of inflammatory diseases
FR2697253B1 (en)	1994-12-02	2-Aminopyrimidine-4-carboxamide derivatives, their preparation and their therapeutic use.
RU95122486A (en)	1998-01-27	MEANS FOR TREATMENT OF TICHOUS HYPERKINESIS
FR2694702B3 (en)	1994-07-29	PERFECTED THERAPEUTIC BRACELET.
FI882383L (en)	1988-11-22	DERIVATIVES OF 3-METHYLACYLAMINO-5,6,7,8-TETRAHYDROIMIDAZO/1,2-A/-PYRIDINE, DERAS FRAMSTAELLNING OCH ANVAENDNING I THERAPY.